The IRIS device is FDA approved and designed to quickly transmit images to a bank for ophthalmologists to look for signs of vision impairment caused by diabetes, heart disease and other pathologies, according to the report. The device can be used in clinics and healthcare departments.
Dr. Gupta also serves as founder and chief medical officer for IRIS and chairman of the Pensacola, Fla.-based Retina Specialty Institute.
More Articles on Surgery Centers:
12 Statistics on Small ASC Gross Charges
ASC Ownership Sales: 4 Things to Consider Beforehand
10 Keys to Effective Internal ASC Claim Audits
